efavirenz/emtricitabine/tenofovir disoproxil zentiva
zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir
simvastatin orion 80 mg filmdragerad tablett
posaconazole teva 100 mg gastro-resistant tablets
teva b.v. - posaconazole - gastro-resistant tablet - 100 milligram(s) - posaconazole
posaconazole clonmel 100 mg gastro-resistant tablets
clonmel healthcare ltd - posaconazole - gastro-resistant tablet - 100 milligram(s) - triazole derivatives; posaconazole
posaconazole clonmel 100 mg gastro-resistant tablets
clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - posaconazole - gastro-resistant tablet - posaconazole 100 mg - antimycotics for systemic use
posaconazol al 100 mg magensaftresistente tabletten
omeprazol orion 40 mg enterokapsel, hård
omeprazol orion 10 mg enterokapsel, hård
omeprazol orion 20 mg enterokapsel, hård
rivaroxaban stada 20 mg filmdragerad tablett